KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) EBT Margin: 2009-2025

Historic EBT Margin for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to 16.42%.

  • Thermo Fisher Scientific's EBT Margin fell 2.00% to 16.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.22%, marking a year-over-year increase of 9.00%. This contributed to the annual value of 16.41% for FY2024, which is 172.00% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's EBT Margin stood at 16.42%, which was up 4.28% from 15.74% recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's EBT Margin ranged from a high of 27.79% in Q2 2021 and a low of 12.73% during Q2 2023.
  • Moreover, its 3-year median value for EBT Margin was 15.98% (2023), whereas its average is 15.65%.
  • The largest annual percentage gain for Thermo Fisher Scientific's EBT Margin in the last 5 years was 1,450bps (2021), contrasted with its biggest fall of 1,006bps (2021).
  • Over the past 5 years, Thermo Fisher Scientific's EBT Margin (Quarterly) stood at 17.40% in 2021, then plummeted by 188bps to 15.52% in 2022, then soared by 46bps to 15.98% in 2023, then soared by 105bps to 17.03% in 2024, then fell by 2bps to 16.42% in 2025.
  • Its last three reported values are 16.42% in Q3 2025, 15.74% for Q2 2025, and 15.63% during Q1 2025.